Beattie W, Yang H
Br J Anaesth. 2019; 123(2):97-100.
PMID: 31248641
PMC: 6676158.
DOI: 10.1016/j.bja.2019.05.039.
Dobson G
Front Surg. 2015; 2:43.
PMID: 26389122
PMC: 4558465.
DOI: 10.3389/fsurg.2015.00043.
Preckel B, Poels M, Wappler F, Schlack W, Buhre W
Anaesthesist. 2010; 59(7):643-51.
PMID: 20383478
DOI: 10.1007/s00101-010-1703-0.
Goto K, Hagiwara S, Hidaka S, Yamamoto S, Kusaka J, Yasuda N
J Anesth. 2010; 24(1):11-6.
PMID: 20052497
DOI: 10.1007/s00540-009-0849-x.
Costa P, Donegani E, DePaulis R, Ottino G, Villani M, Matani A
Tex Heart Inst J. 1986; 13(1):53-60.
PMID: 15226832
PMC: 324598.
THE DANGER OF PREOPERATIVE WITHDRAWAL OF PROPRANOLOL.
Romagnoli A, Sabawala P
Cardiovasc Dis. 1974; 1(1):15-16.
PMID: 15216001
PMC: 287453.
Issues in the perioperative management of the elderly patient with cardiovascular disease.
Sear J, Higham H
Drugs Aging. 2002; 19(6):429-51.
PMID: 12149050
DOI: 10.2165/00002512-200219060-00003.
Low-dose propranolol for the protection of the left ventricle from ischaemic damage.
Brown A, Krause B, Morritt G
Thorax. 1981; 36(11):814-22.
PMID: 7330803
PMC: 471820.
DOI: 10.1136/thx.36.11.814.
Haemodynamic dose-response effects of i.v. metoprolol in coronary heart disease.
HENDRY W, Silke B, Taylor S
Eur J Clin Pharmacol. 1981; 19(5):323-7.
PMID: 7238560
DOI: 10.1007/BF00544581.
Medical evaluation before operation.
Elliot D, Linz D, Kane J
West J Med. 1982; 137(4):351-8.
PMID: 7179956
PMC: 1274135.
Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.
Holley F, Ponganis K, Stanski D
Clin Pharmacokinet. 1982; 7(3):234-51.
PMID: 7047043
DOI: 10.2165/00003088-198207030-00004.
Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study.
Silverman N, Wright R, Levitsky S
Ann Surg. 1982; 196(2):194-7.
PMID: 6979982
PMC: 1352475.
DOI: 10.1097/00000658-198208000-00012.
Preoperative management of proximal lesions of the left coronary artery system: surgical implications.
Krebber H, Szarnicki R, Hill J
West J Med. 1981; 134(6):491-5.
PMID: 6973242
PMC: 1272835.
Concentration-effect and time-effect relationships of carteolol.
Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T, Kushida K
Eur J Clin Pharmacol. 1983; 25(6):749-57.
PMID: 6141053
DOI: 10.1007/BF00542514.
Anaesthetic problems associated with the treatment of cardiovascular disease: II. Beta-adrenergic antagonists.
Chung D
Can Anaesth Soc J. 1981; 28(2):105-13.
PMID: 6113884
DOI: 10.1007/BF03007252.
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
Greenblatt D, Koch-Weser J
Drugs. 1974; 7(1):118-29.
PMID: 4151696
DOI: 10.2165/00003495-197407010-00008.
Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair.
Barazzone C, Jaccard C, Berner M, Dayer P, Rouge J, Oberhansli I
Br Heart J. 1988; 60(2):156-61.
PMID: 3415875
PMC: 1216539.
DOI: 10.1136/hrt.60.2.156.
Esmolol.
Ramsay J
Can J Anaesth. 1991; 38(2):155-8.
PMID: 1673642
DOI: 10.1007/BF03008136.
Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery.
Coltart D, CAYEN M, Stinson E, Goldman R, Davies R, Harrison D
Br Heart J. 1975; 37(12):1228-34.
PMID: 1225337
PMC: 482945.
DOI: 10.1136/hrt.37.12.1228.
Acute coronary syndromes following abrupt cessation of oral propranolol therapy.
MIZGALA H, Counsell J
Can Med Assoc J. 1976; 114(12):1123-6.
PMID: 942572
PMC: 1957150.
